Iovance Biotherapeutics, Inc. (IOVA)
3.38
+0.08
(+2.42%)
USD |
NASDAQ |
Apr 07, 14:27
Iovance Biotherapeutics Accounts Receivable (Annual) : 82.45M for Dec. 31, 2025
Accounts Receivable (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Annual) Benchmarks
| Orthofix Medical, Inc. | 135.75M |
| InfuSystem Holdings, Inc. | 22.90M |
| Axogen, Inc. | 26.17M |
| KalVista Pharmaceuticals, Inc. | 2.593M |
| Lantheus Holdings, Inc. | 358.64M |